Clinical Trials Browser

OTHER × Fallopian Tube Neoplasms × regorafenib × Clear all

NCT02278783 2017-10-06

Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Phase 2 Terminated

1 enrolled 5 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms